Skip to content
    Full Stack Medicine Logo

    News

    Research and trial news from journals we track.

    Top Stories

    Ranked by reader clicks and relevance, last 14 days.

    1. STIKO Updates Immunization Guidelines for Older Adults

      Deutsche medizinische WochenschriftKwetkat et al

    2. Diagnostic Accuracy of Brief Cognitive Assessments for Early Impairment Detection in Dementia

      Alzheimer's & DementiaLoveless et al

    3. Plozasiran for Severe Hypertriglyceridemia and Acute Pancreatitis Risk

      The New England journal of medicineWatts et al

    4. PreVitaCOV Trial: Low-Dose Prednisolone and B Vitamins for Post-COVID-19 Syndrome

      EClinicalMedicineGágyor et al

    5. Oral Orforglipron in Overweight Adults With Adiposity Complications: ATTAIN-1 Post Hoc Analysis

      Obesity pillarsAlmandoz et al

    Clinical Trials

    Illustration for: HLX14 (Investigational) Demonstrates Efficacy Equivalence to EU-Denosumab in Phase 3 Trial
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAXin et alIllustration

    HLX14 (Investigational) Demonstrates Efficacy Equivalence to EU-Denosumab in Phase 3 Trial

    In a phase 3 trial of women with osteoporosis at high fracture risk, biosimilar HLX14 showed efficacy and pharmacodynamic equivalence to EU-denosumab.

    Real-World Studies

    Illustration for: Non-Allergist Penicillin Allergy De-Labelling in Acute Medicine
    JAC-antimicrobial resistanceToner et alIllustration

    Non-Allergist Penicillin Allergy De-Labelling in Acute Medicine

    A non-allergist penicillin allergy de-labelling protocol successfully de-labelled 59 of 60 adult inpatients, with zero cases of anaphylaxis.

    Stay updated

    Weekly highlights. Unsubscribe anytime.

    Guidelines & Consensus

    Illustration for: Robust Older Patients Should Be Eligible for Lung Cancer Screening: SIOG
    JTO clinical and research reportsSteimer et alIllustration

    Robust Older Patients Should Be Eligible for Lung Cancer Screening: SIOG

    An SIOG consensus statement recommends using geriatric assessment to determine lung cancer screening eligibility for robust patients older than 80 years.

    More news